Clinical trials

Recherche d’études cliniques

Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.

Réinitialiser

Études cliniques 467

Étude / NCT ⇅ Molécule ⇅ Maladie ⇅ Phase ⇅ Statut ⇅ Résultat ⇅ Sponsor ⇅ Pays / centres ⇅ Période ⇅ Détail
NCT05281770
Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real …
Erenumab Migraine À vérifier UNKNOWN En attente / non publié Amgen Austria · Clinic Hietzing, Vienna, Austria | Medical … 2022-10-01 → 2025-12-01 Ouvrir
NCT05617339
Tailored Digital Treatment for Migraine
Tailored Digital Treatment for Mi… Migraine Non applicable UNKNOWN En attente / non publié Vastra Gotaland Region Sweden · FoU primary care Södra Älvsborg, Borås, Swed… 2023-01-01 → 2025-12-31 Ouvrir
NCT03235479
Safety and Efficacy Study in Adult Subjects With Acute Migraines
Rimegepant Migraine Phase 3 COMPLETED En attente / non publié University of South Florida United States · Advanced Pharma CR, LLC, Miami, Unite… 2017-07-18 → 2018-01-26 Ouvrir
NCT03237845
Safety and Efficacy in Adult Subjects With Acute Migraines
Rimegepant Migraine Phase 3 COMPLETED En attente / non publié University of South Florida United States · AGA Clinical Trials, Hialeah, United … 2017-07-27 → 2018-01-31 Ouvrir
NCT03266588
Open Label Safety Study in Acute Treatment of Migraine
Rimegepant Migraine Phase 2/3 COMPLETED En attente / non publié University of South Florida United States · AGA Clinical Trials, Hialeah, United … 2017-08-30 → 2019-07-15 Ouvrir
NCT04968093
MINDKIDS — Mindfulness for Adolescents for CM and HFEM
MINDKIDS — Mindfulness for Adoles… Migraine Non applicable COMPLETED En attente / non publié Fondazione I.R.C.C.S. Istituto Ne… Italy · Fondazione IRCCS Istituto Neurologico C. Best… 2016-01 → 2021-01 Ouvrir
NCT04905654
Migraine Inducing Effect of Levcromakalim in Patients With Migraine Wit…
Levcromakalim Migraine Non applicable COMPLETED En attente / non publié Danish Headache Center Denmark · Danish Headache Center, Glostrup Municipali… 2021-09-29 → 2023-05-16 Ouvrir
NCT05454319
CER-MIG-1 — Cerebri Biofeedback Feasibility Trial
Biofeedback Migraine Non applicable COMPLETED En attente / non publié Nordic Brain Tech AS Norway · St.Olavs Hospital HF, Trondheim, Norway 2022-06-01 → 2022-09-27 Ouvrir
NCT03009019
Efficacy, Tolerability, and Safety of DFN-15
DFN-15 Active Migraine Phase 3 COMPLETED En attente / non publié BioDelivery Sciences International United States · Site 601, West Palm Beach, United Sta… 2016-12 → 2019-05 Ouvrir
NCT03006276
Efficacy, Tolerability, and Safety Study of DFN-15
DFN-15 Active Migraine Phase 3 COMPLETED En attente / non publié BioDelivery Sciences International United States · Site 701, Oklahoma City, United State… 2016-12 → 2019-05 Ouvrir
NCT05742191
DST — The Effect of Daylight Saving Time Transitions on Sleep and Migra…
DST — The Effect of Daylight Savi… Migraine À vérifier UNKNOWN En attente / non publié OSF Healthcare System United States · OSF HealthCare Saint Francis Medical … 2023-02-06 → 2023-06-01 Ouvrir
NCT05085483
Ketone for Migraine Prevention
Ketone for Migraine Prevention Migraine Non applicable COMPLETED En attente / non publié Société des Produits Nestlé (SPN) Canada · Diex Research Sherbrooke Inc., Sherbrooke, C… 2021-10-11 → 2022-11-28 Ouvrir
NCT03963232
PERSIST — A Study of Galcanezumab (LY2951742) in Participants With Epis…
Galcanezumab Migraine Phase 3 COMPLETED En attente / non publié Eli Lilly and Company China, India, Russia · Academician I.P. Pavlov First … 2019-07-30 → 2022-03-11 Ouvrir
NCT05891808
miR-155 Expression in Episodic and Chronic Migraine
miR-155 Expression in Episodic an… Migraine À vérifier UNKNOWN En attente / non publié IRCCS National Neurological Insti… Italy · IRCCS Mondino Foundation, Pavia, Italy 2020-09-22 → 2024-01-01 Ouvrir
NCT04740827
ELEVATE — Atogepant for Prophylaxis of Migraine in Participants Who Fai…
Atogepant 60 mg Migraine Phase 3 COMPLETED En attente / non publié Fundación de Investigación Bioméd… United States, Australia, Canada, Czechia, Denmark, F… 2021-03-05 → 2022-08-04 Ouvrir
NCT05449145
The Effects of Vitamin D Plus Omega-3 Polyunsaturated Fatty Acids in Pa…
The Effects of Vitamin D Plus Ome… Migraine Non applicable UNKNOWN En attente / non publié Kuang Tien General Hospital Taiwan · Kuang Tien General Hospital, Taichung, Taiwan 2022-05-01 → 2024-04-15 Ouvrir
NCT03927144
Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients
AMG334 Migraine Phase 4 COMPLETED En attente / non publié Amgen United States, Argentina, Austria, Belgium, Czechia, … 2019-05-15 → 2022-09-30 Ouvrir
NCT05162664
CENSENMI — Presence of Signs of Central Sensitization in Episodic and C…
CENSENMI — Presence of Signs of C… Migraine Non applicable COMPLETED En attente / non publié University Ghent Belgium · Ghent University, Ghent, Belgium 2021-10-15 → 2022-10-01 Ouvrir
NCT06155123
HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment W…
Monoclonal antibody targeting the… Migraine À vérifier UNKNOWN En attente / non publié IRCCS National Neurological Insti… Italy · Headache Science & Neurorehabilitation Center… 2020-01-14 → 2024-06 Ouvrir
NCT06243874
Comparison of Occipital Nerve and Sphenopalatine Ganglion Blockade
greater occipital nerve block Migraine Non applicable COMPLETED En attente / non publié Assiut University Turkey (Türkiye) · Ankara University, Ankara, Turkey … 2023-09-01 → 2024-01-01 Ouvrir
NCT05226559
MIGPHYSTREAT — Effectiveness of Multimodal Physical Therapy in Migraine
MIGPHYSTREAT — Effectiveness of M… Migraine Non applicable UNKNOWN En attente / non publié Neuromed IRCCS Italy · IRCCS Neuromed, Pozzilli, Italy 2022-02-24 → 2025-05 Ouvrir
NCT00329771
Research Study to Determine Sensitivity to Gentle Touch and Pressure Du…
Research Study to Determine Sensi… Migraine À vérifier COMPLETED En attente / non publié Thomas Jefferson University United States · Jefferson Headache Center, Philadelph… 2006-03 → 2008-03 Ouvrir
NCT04698525
Comparative Study Between Valproate and Memantine in the Prophylactic M…
Valproate Sodium Migraine Phase 3 COMPLETED En attente / non publié Universidad Autonoma de San Luis … Mexico · Hospital Central Dr. Ignacio Morones Prieto,… 2019-02-15 → 2020-01-15 Ouvrir
NCT04265755
INTERROGATE — Biomarker and Genetic Predictors of Erenumab Treatment Re…
Erenumab Migraine Phase 4 COMPLETED En attente / non publié Amgen Denmark, Iceland · Glostrup Hospital, Glostrup Munici… 2020-10-26 → 2023-01-18 Ouvrir
NCT05127486
CHALLENGE-MIG — A Study of Galcanezumab (LY2951742) in Adult Participan…
Galcanezumab Migraine Phase 4 COMPLETED En attente / non publié Eli Lilly and Company United States · Accel Research Sites- Clinical Resear… 2021-12-06 → 2023-05-23 Ouvrir